Albiglutide Versus Placebo in Insulin-treated Subjects With New-onset Type 1 Diabetes Mellitus

NCT02284009 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

BIOLOGICAL: Albiglutide weekly injection
BIOLOGICAL: Placebo weekly injection
BIOLOGICAL: Insulin

Sponsor

GlaxoSmithKline